1.
Fitoterapia
; 169: 105620, 2023 Sep.
Article
En
| MEDLINE
| ID: mdl-37490982
Natural psychedelic compounds are emerging as potential novel therapeutics in psychiatry. This review will discuss how natural psychedelics exert their neurobiological therapeutic effects, and how different neurotransmission systems mediate the effects of these compounds. Further, current therapeutic strategies for depression, and novel mechanism of action of natural psychedelics in the treatment of depression will be discussed. In this review, our focus will be on N, N-dimethyltryptamine (DMT), reversible type A monoamine oxidase inhibitors, mescaline-containing cacti, psilocybin/psilocin-containing mushrooms, ibogaine, muscimol extracted from Amanita spp. mushrooms and ibotenic acid.
Hallucinogens , Hallucinogens/pharmacology , Hallucinogens/therapeutic use , Depression/drug therapy , Molecular Structure , N,N-Dimethyltryptamine/pharmacology , Neurotransmitter Agents